NCT04432532

Neuroendocrine and Adrenal Tumors

Neuroendocrine and Adrenal Tumors: Biochemical, Histopathologic and Genetic Studies

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: —

Summary

This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in conjunction with IRB#831990 which is a retrospective protocol. The University of Pennsylvania will be a contributing site with the University of Michigan as the coordinating site for the A5 alliance, a multi-institutional collaborative designed to study neuroendocrine and adrenal tumors.

Conditions

• Neuroendocrine Tumors
• Adrenal Tumor

Interventions

Type	Name	Description
OTHER	No intervention	There are no interventions

Timeline

• Start date: 2025-12-01
• Primary completion: 2027-01-01
• Completion: 2028-01-01
• First posted: 2020-06-16
• Last updated: 2025-02-10